Bleeding arising from the use of exogenous steroids

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 13, Issue 2, 1999, Pages 203-222

  Fraser, Ian S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Breakthrough bleeding; Dysfunctional uterine bleeding; Hormonal contraceptives; Hormone replacement therapy; Mechanisms of bleeding

Indexed keywords

CONTRACEPTIVE AGENT; STEROID;

FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; MENSTRUATION; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW; UTERUS BLEEDING;

CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENSTRUATION; STEROIDS; UTERINE HEMORRHAGE;

EID: 0032871346     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1053/beog.1999.0018     Document Type: Article

References (54)

1. Alexander NJ, & d'Arcangues C (eds) (1992) Steroid Hormones and Uterine Bleeding, pp 344. Washington: American Association for the Advancement of Science.
2. Alvarez-Sanchez F, Brache V, Thevenin F et al (1996) Hormonal treatment for bleeding irregularities in Norplant implant users. American Journal of Obstetrics and Gyneco/ogy 174:919-922.
3. d'Arcangues C, Odlind V & Fraser IS (1992) Dysfunctional uterine bleeding induced by exogenous hormones. In Alexander NJ & d'Arcangues C (eds) Steroid Hormones and Uterine Bleeding, pp 81-105. Washington: AAAS Press.
4. d'Arcangues C, Fraser IS, Newton JR & Odlind V (eds) (1990) Contraception and Mechanisms of Endometr/a/ Bleeding, p 547. Cambridge: Cambridge University Press.
5. Balogh SA, Mishell DR Jr, Lacarra M et al ( 1994) A contraceptive vaginal ring releasing norethindrone acetate and ethinyl estradiol. Contraception SO: 517-533.
6. Betsey EM & Parley TMM (1988) The analysis of menstrual bleeding patterns: a review. Contraception 38: 129-156.
7. Belsey EM & Carlson N (I99I) The description of menstrual bleeding patterns: towards fewer measures. Statistics in Medicine 10: 267-284.
8. Belsey EM, Machin D & d'Arcangues C (1986) The analysis of vaginal bleeding patterns induced by fertility regulating methods. Contraception 34: 253-260.
9. Belsey EM & Task Force on Long-Acting Systemic Agents for Fertility Regulation (I988a) The association between vaginal bleeding patterns and reasons for discontinuation of contraceptive use. Contraception 38: 207-225.
10. Belsey EM & Task Force on Long-Acting Systemic Agents for Fertility Regulation (19886) Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 38: 181-206.
11. Belsey EM, Pinol APY & Task Force on Long-Acting Systemic Agents for Fertility Regulation ( 1997) Menstrual bleeding patterns in untreated women. Contraception 55: 57-65.
12. Cole SK, Billewicz WZ & Thomson AM (1971) Sources of variation in menstrual blood loss. Journal of Obstetrics and Gynaeco/ogy of the British Commonwealth 78: 933-939.
13. Corner GW (1942) The Hormones in Human Reproduction. Princeton: Princeton University Press.
14. Critchley HOD, Bailey DA, Au CL et al (1993) Immuno histochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Humon Reproduction 8: 1632-1639.
15. Diaz S, Croxatto HB, Pavez M et al (1990) Clinical aspects of treatments for prolonged bleeding in users of Norplant implants. Contraception 42: 97-109.
16. Diczfalusy E, Fraser IS & Webb FTG (eds) (1980) Endometriat Bleeding and Steroidal Contraception, pp 440. Bath, UK: Pitman Press.
17. Findlay J & Affandi B (eds) (1996) Menstrual disorders and progestin contraception. Human Reproduction 11 (supplement 2): 1-190.
18. Fraser IS (1983) A survey of approaches to management of menstrual disturbances in women using injectable contraceptives. Contraception 28: 38S-397.
19. Fraser IS (1994) Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Contraception 49: 399-420.
20. Fraser IS (1998) The menstrual bleeding pattern during use of a levonorgestrel intrauterine system. In Johansson EDB (ed.) Mirena, The Levonorgestrel Intrauterine System, pp 41-52. New York: Parthenon Publishing Group.
21. Fraser IS & Weisberg E (I98I) A comprehensive review of injectable contraception with special emphasis on depot Medroxyprogesterone acetate. Medical Journal of Australia I (supplement I): 1-19.
22. Fraser IS, McCarron G & Markham R (1984) A preliminary study of factors influencing perception of menstrual blood loss volume. American Journal of Obstetrics and Gynecohgy 149: 788-793.
23. Fraser IS, Hickey M & Song JY (1996) A comparison of mechanisms underlying disturbances in bleeding caused by spontaneous dysfunctional, uterine bleeding or hormonal contraception. Human Reproduction II (supplement 2): 165-178.
24. Fraser IS, McCarron G, Markham R & Resta T (1985) Blood and total fluid content of menstrual discharge. Obstetrics and Cynecology 65: 194-198.
25. Fraser IS, Titinen A, Affandi B et al (1998) Norplant Consensus Statement and Background Review. Contraception 57: I -9.
26. Gray RH (1980) Patterns of bleeding associated with the use of Steroidal contraceptives. In Diczfalusy E, Fraser IS & Webb FTG (eds) Endometrial Bleeding and Steroidal Contraception, pp 14-19, Bath, England: Pitman Press.
27. Hall PE & Fraser IS (1983) Monthly injectable contraceptives. In Mishell DR Jnr (ed.) Long Acting Steroid Contraception. Advances in Reproductive Endocrinology and Fertility, volume 2, pp 65-88. New York: Raven Press.
28. Hallberg L, Hogdahl AM, Nilsson L & Rybo G (1966) Menstrual blood loss-a population study. Acta Obstetrica et Cynecologica Scandinavica 45: 320-351.
29. Hickey M, Fraser IS, Dwarte D & Graham S (1996) The endometrium in Norplant users: an hysteroscopic study. Human Reproduction 11 (supplement 2): 35-444.
30. Indian Council of Medical Research (1989) Randomised clinical trial with uterine devices. A 36-month study. Contraception 39: 37-52.
31. Johannisson E & Landgren BM (1980) Bleeding irregularities with Steroidal contraceptives in relation to changes in circulating hormones. In Diczfalusy E, Fraser IS & Webb FTG (eds) Endometrial Bleeding and Steroidal Contraception, pp 291 -317. Bath, England: Pitman Press.
32. Landgren BM & Diczfalusy E (1980) Hormonal effects of the 300 (Jg norethisterone minipill. Contraception 21:87-113.
33. Lau T, Witjaksono J & Rogers PAW (1996) In-situ hybridisation studies on endometrial progesterone receptors in Norplant users and during the normal menstrual cycle. Human Reproduction 11 (supplement 2): 90-94.
34. Luukkainen T, Allonen H, Haukkamaa M et al (1987) Effective contraception with the levonorgestrelreleasing intrauterine device. Contraception 36: 169-179.
35. Markee JE (1948) Morphological basis for menstrual bleeding. Relation of regression to the initiation of bleeding. Bulletin of the New York Academy of Mediane 24: 253-268.
36. Nilsson CG & Holma P (I98I) Menstrual blood loss with contraceptive subdermal levonorgestrel implants. Fertility and Sterility 35: 304-306.
37. Olsson SE, Odlind V, Johansson EDB & Sivin I (1988) Contraception with Norplant implants and Norplant2 implants. Contraception 37: 61-73.
38. Population Council (1990) Norplant levonorgestrel implants. A Summary of Scientific Data. New York: Population Council.
39. Rodriguez G, Faundes-Latham A & Atkinson LE ( 1976) An approach to the analysis of menstrual patterns in the critical evaluation of contraceptives. Studies in Family Planning 7: 42-51.
40. Said S, Sadek W, Rocca M et al (1996) Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. Human Reproduction 11 (supplement 2): 1-13.
41. Sivin I (1983) Clinical effects of subdermal implants for contraception. In Mishell JRJr (ed.) Long-Acting Steroid Contraception and Advances in Reproductive Endocrinology and Infertility, Volume 2, pp 89-116. New York: Raven Press.
42. Sivin I, Mishell DR Jr, Victor A et al (1981) A multicenter study of levonorgestrel-oestradiol contraceptive vaginal rings. I: use-effectiveness. Contraception 24: 341-358.
43. Sivin I, Stern J, DiazJ etal (!987)Twoyearsof intrauterine contraception with levonorgestrel and with copper. Contraception 35: 245-2SS.
44. Snowden R (1977) The statistical analysis of menstrual bleeding patterns. Journal of Biosocial Science 9: 107-120.
45. Snowden R & Christian B (1983) Patterns and Perceptions of Menstruation, pp 339. London: Croom Helm.
46. Treloar AE, Boynton RE, Behn BG & Brown BW (1967) Variation of the human menstrual cycle through reproductive life. International Journal of Fertility 12: 77-126.
47. Vollman RF (1977) The Menstrua/ Cycle, pp 193. Philadelphia: W.B. Saunders.
48. WHO Task Force on Long Acting Systemic Agents for Fertility Regulation ( 1977) Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. Contraception 15:513-533.
49. WHOTask Force on Long-Acting Systemic Agents for Fertility Regulation (1983) Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone oenanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Contracept/on 28: 1-20.
50. WHO Task Force on Long-acting Systemic Agents for Fertility Regulation (1986) A multicentre phase III comparative clinical trial of depot medroxyprogesterone acetate given in three-monthly doses of lOOmg and ISOmg. Contraception 34: 223-235.
51. WHO Task Force on Long-acting Systemic Agents for Fertility Regulation (1988) A multicentre phase III comparative clinical study of two hormonal contraceptive preparations given once a month by intramuscular injection. Contraception 37: 1-20.
52. WHO Task Force on Long-acting Systemic Agents for Fertility Regulation (1990) Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. Contraception 41: 105-124.
53. WHO Task Force on Oral Contraceptives (1982) A randomised, double-blind study of two combined and two progestogen-only oral contraceptives. Contraception 25: 243-252.
54. Zador G (1979) Fertility regulation using 'Triphasic' administration of ethinyl oestradiol and levonorgestrel in comparison with the 30 plus 150 -4ig fixed dose regime. Acta Obstetrica et Gynecohgica Scandinavica 88 (supplement): 43-48.